Matches in Nanopublications for { ?s ?p "[On the contrary, RAR-beta(2) expression did neither differ significantly between conventional and chromophobe RCC (p=0.91) nor between malignant and normal kidney tissue (p>or=0.47).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP841931.RArWxJfRHLA9ZR9ceuasMqu7A-EaodNT7nVTtvuVmrTDI130_assertion description "[On the contrary, RAR-beta(2) expression did neither differ significantly between conventional and chromophobe RCC (p=0.91) nor between malignant and normal kidney tissue (p>or=0.47).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP841931.RArWxJfRHLA9ZR9ceuasMqu7A-EaodNT7nVTtvuVmrTDI130_provenance.
- NP519171.RAvSExcAlVKoi-0KztxN6U4K3W21oObmhttKhItqmHzWw130_assertion description "[On the contrary, RAR-beta(2) expression did neither differ significantly between conventional and chromophobe RCC (p=0.91) nor between malignant and normal kidney tissue (p>or=0.47).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519171.RAvSExcAlVKoi-0KztxN6U4K3W21oObmhttKhItqmHzWw130_provenance.
- NP587622.RAH-HNgvKlhLgHq1TQVJ6PXY2XUsy58MKl42_wFst2_G0130_assertion description "[On the contrary, RAR-beta(2) expression did neither differ significantly between conventional and chromophobe RCC (p=0.91) nor between malignant and normal kidney tissue (p>or=0.47).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587622.RAH-HNgvKlhLgHq1TQVJ6PXY2XUsy58MKl42_wFst2_G0130_provenance.
- NP519170.RAGLJnk0xQ8q13WdFKGway7BWF3M2AomFJNnDi6aExUWs130_assertion description "[On the contrary, RAR-beta(2) expression did neither differ significantly between conventional and chromophobe RCC (p=0.91) nor between malignant and normal kidney tissue (p>or=0.47).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519170.RAGLJnk0xQ8q13WdFKGway7BWF3M2AomFJNnDi6aExUWs130_provenance.